Pulse.

a daily field guide to health research that matters

◆ Console

‹ back to Tue · 27 Oct 2026

Daily digest

Tue · 27 Oct 2026

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.

📅 PUBMED DAILY TRIAGE — 2026-10-27 Window: 2026-10-26T09:00:00Z → 2026-10-27T09:00:00Z (CRDT) Topics scanned: 10 | Articles reviewed: 120 | Candidates evaluated: 120 High priority: 9 | Standard: 41 | Low/archive: 0 | Unsolicited finds: 8 Run status: SUCCESS

🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic

T1: Hematologic malignancies

PMID42933440 · Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study. · 9/10 · Serious adverse events occurred in 31 (41%) patients with zamto-cel and 50 (66%) with R-GemOx, most commonly malignant neoplasm progression (11 [14%] and 38 [50%]), cytokine release syndrome (CRS; six [8%] and none), and immune effector cell-associated neurotoxicity syndrome (four [5%] and none).

T2: CBC-based diagnostics and machine learning in hematology: No high-priority finds today (best candidate scored 0/10) T3: Early cancer detection: No high-priority finds today (best candidate scored 6/10) T4: AI/ML in clinical diagnostics and imaging: No high-priority finds today (best candidate scored 6/10) T5: Precision oncology and genomic medicine: No high-priority finds today (best candidate scored 7/10)

T6: Novel therapeutics: immunotherapy, CAR-T, targeted therapy

PMID42933459 · Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial. · 10/10 · Baili-Bio (Chengdu) Pharmaceutical, CAMS Innovation Fund for Medical Sciences, Noncommunicable Chronic Diseases-National Science and Technology Major Project, National High Level Hospital Clinical Research Funding, and the National Natural Science Foundation of China. PMID42933461 · Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China. · 10/10 · In participants with EGFR-mutated advanced non-squamous NSCLC after progression on third-generation EGFR TKIs, iza-bren significantly prolonged progression-free survival, although treatment-related adverse events of grade 3 or worse were more frequent than with chemotherapy. PMID42933440 · Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study. · 9/10 · Serious adverse events occurred in 31 (41%) patients with zamto-cel and 50 (66%) with R-GemOx, most commonly malignant neoplasm progression (11 [14%] and 38 [50%]), cytokine release syndrome (CRS; six [8%] and none), and immune effector cell-associated neurotoxicity syndrome (four [5%] and none). PMID42934012 · Neoadjuvant Therapy in Patients with Upper Tract Urothelial Cancer: An Updated Systematic Review and Meta-analysis. · 9/10 · NAC was associated with favorable oncological outcomes compared with RNU alone. PMID42933460 · Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial. · 8/10 · Sac-TMT significantly improved progression-free survival and overall survival versus TPC in patients with advanced or recurrent endometrial cancer previously treated with platinum-based chemotherapy and immunotherapy.

T7: Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk

PMID42934030 · [LDL-c and residual cardiovascular risk in patients with coronary artery disease]. · 8/10 · This article aims to explore the underlying causes of and potential solutions to this therapeutic gap, which is associated with an increased risk of cardiovascular morbidity and mortality.

T8: Aging, longevity, and population health: No high-priority finds today (best candidate scored 7/10) T9: Rare diseases with high unmet need: No high-priority finds today (best candidate scored 6/10)

🟢⚪ STANDARD (5-7) — Top by Topic

T1: Hematologic malignancies

PMID42933695 · Bone Marrow Cell Depletion in Myelofibrosis Is Associated With High-Risk Features and Shortened Survival: A Bone Marrow Pathology Group Study. · 6/10 · Other PMID42933765 · Nuclear BCL10 translocation contributes to lymphoma progression and poor prognosis of peripheral T-cell lymphomas. · 5/10 · Other PMID42934072 · Prediction of Double-Expressor Lymphoma in Diffuse Large B-Cell Lymphoma Using a Non-invasive Model Based on [18F] FDG PET/CT and Stacking. · 5/10 · Diagnostics PMID42932438 · Secondary minimally differentiated acute leukemia with plasmacytoid dendritic cell differentiation (pDC-AML) following chemoradiotherapy for Ewing sarcoma in a child: biallelic EZH2 inactivation. · 4/10 · Other

T3: Early cancer detection

PMID42929655 · Circulating tumor DNA in breast cancer in 2027: advancing liquid biopsy and molecular monitoring. · 6/10 · Early Detection PMID42934010 · [Genomic alterations in thymic epithelial tumors: State of knowledge, and the interest of liquid biopsy]. · 6/10 · Early Detection PMID42933447 · Development of the Children's Oncology Group long-term follow-up guideline for cancer genetics evaluation in childhood cancer survivors. · 5/10 · Early Detection PMID42928566 · Community-based learning disabilities nurses supporting patients with breast, cervical, and bowel cancer screening. · 4/10 · Early Detection PMID42928652 · Development of an HPV Self-Collection Brochure for Unhoused Individuals Using Learner Verification and Revision. · 4/10 · Early Detection

T4: AI/ML in clinical diagnostics and imaging

PMID42934014 · A deep learning model for detection and staging of osteonecrosis of the femoral head on x-ray images: a retrospective, large-scale, multicentre study in China. · 6/10 · Diagnostics PMID42933566 · Machine learning-based stability optimization design and virtual screening of the anti-pulmonary fibrosis peptide DR3penA. · 5/10 · Diagnostics PMID42933630 · Combining Single-Cell Data with Machine Learning Uncovers the Molecular Landscape of Keratoconus. · 5/10 · Diagnostics PMID42934072 · Prediction of Double-Expressor Lymphoma in Diffuse Large B-Cell Lymphoma Using a Non-invasive Model Based on [18F] FDG PET/CT and Stacking. · 5/10 · Diagnostics PMID42933474 · Experience with AI-assisted Fracture Detection at a Pediatric Hospital. · 4/10 · Diagnostics

T5: Precision oncology and genomic medicine

PMID42932116 · Patient-Derived Organoids for Predicting Chemotherapy Response in Bladder Cancer: A Multicenter, Real-world Validation Study. · 7/10 · Genomics/Precision Medicine PMID42929655 · Circulating tumor DNA in breast cancer in 2027: advancing liquid biopsy and molecular monitoring. · 6/10 · Early Detection PMID42931883 · Barriers and Opportunities for Implementing Precision Oncology in Geriatric Cancer Care. · 6/10 · Genomics/Precision Medicine

T6: Novel therapeutics: immunotherapy, CAR-T, targeted therapy

PMID42928445 · Design, Synthesis, and Evaluation of Halo-Substituted Flavonols Against Melanoma A375 Cells. · 5/10 · Treatment Innovation PMID42929781 · Colorectal cancers with distinct metastatic potential trigger divergent early T cell responses. · 5/10 · Treatment Innovation PMID42933735 · Intestinal Candida albicans promotes HCC progression and anti-PD-1 resistance via IL-17A and Trem2+ macrophages. · 5/10 · Treatment Innovation

T7: Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk

PMID42929065 · Combining Cognitive Training and Brain Stimulation: A Novel Approach to Address Disordered Eating and Antipsychotic-Induced Weight Gain in People With Severe Mental Illness. · 7/10 · Prevention PMID42933400 · UBT251, a novel triple GLP-1, GIP, and glucagon receptor agonist, in adults with type 2 diabetes: A multicenter, randomized phase 2 trial. · 7/10 · Prevention PMID42933873 · [Efficacy and safety of domestic semaglutide injection in patients with type 2 diabetes mellitus inadequately controlled with metformin: a multicenter, randomized, controlled phase 3 equivalence clinical trial]. · 7/10 · Prevention PMID42933519 · Glucagon-Like Peptide-1 Receptor Agonists and Risk of Arrhythmias: A Network Meta-Analysis. · 6/10 · Prevention PMID42933869 · Early Initiation of SGLT2 inhibitor and Mortality in Heart Failure With Reduced Ejection Fraction: A Target Trial Emulation Study. · 6/10 · Prevention

T8: Aging, longevity, and population health

PMID42928484 · State Design and Use of Medicaid 1915(c) Waivers and Related Benefits to Provide Home- and Community-Based Services to Aging and Disabled Adults: The Medicaid HCBS Waiver Atlas. · 7/10 · Public Health PMID42932244 · Reducing diabetes care costs and district nurse visits through novel insulin regimens. · 7/10 · Public Health PMID42931996 · Post-Translational Protein Acylation in Atrial Fibrillation. · 6/10 · Public Health PMID42928962 · Juvenile psychopathy and its relation to immaturity: Maturational growth mediates associations between adolescent and adult psychopathy scores. · 5/10 · Public Health PMID42928878 · Depression and Heart Failure With Preserved Ejection Fraction: An Inflammatory Perspective. · 4/10 · Public Health

T9: Rare diseases with high unmet need

PMID42930800 · Challenges in the Transition of Patients with Rare Diseases from Pediatric to Adult Care: Toward an Individualized, Person-Centered Model. · 6/10 · Drug Development PMID42932134 · Sirolimus and Immunoglobulin Replacement Therapy in Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS): A Systematic Literature Review. · 6/10 · Drug Development PMID42929308 · Selection of Genetic Conditions for Multi-State Genomic Newborn Screening in BRIDGES-NBS. · 5/10 · Drug Development PMID42933239 · Health literacy in rare diseases: Associations with perceived healthcare organization, and nursing visibility. · 5/10 · Drug Development PMID42928743 · Cavernous Sinus Thrombosis in a Three-Year-Old Male. · 4/10 · Drug Development

💡 UNSOLICITED FINDS

PMID42929759 · The genetic landscape of RAG deficiency: Novel and founder variants in a large Algerian cohort. · 7/10 · These findings prioritize functional validation of uncertain-significance variants and underscore the need for NBS and expanded transplant access to translate diagnosis into survival. PMID42929403 · LINC01116 promotes the progression of papillary thyroid carcinoma by regulating the apoptosis of bone marrow mesenchymal stem cells. · 6/10 · LINC01116 is significantly upregulated in PTC and serves as an independent prognostic biomarker. PMID42929478 · Haemodynamic and Respiratory Effects of Dexmedetomidine as an Adjuvant to Oxycodone Patient-Controlled Analgesia After Lumbar Spinal Fusion: A Post Hoc Analysis of the DoseRespDex Randomised Controlled Trial. · 6/10 · No correlation between plasma concentrations of dexmedetomidine and haemodynamic parameters was demonstrated. PMID42928975 · TIMS Techniques for Measuring Strontium Isotope Ratios in Apatite Grains and Application to Igneous Rock Petrology. · 5/10 · This approach represents a cost-effective and time-efficient alternative to traditional whole-rock analyses, with strong potential for large-scale isotopic applications in orogenic terrains. PMID42929408 · Exploring the association of quercetin with liver fibrosis through network pharmacology and 16S rRNA gene sequencing. · 5/10 · Histopathology and microbiome analyses indicated that quercetin intervention was associated with altered liver histopathological features and shifts in gut microbiota composition in rats with CCl4-induced liver fibrosis. PMID42929419 · Study on the molecular mechanism of bone marrow mesenchymal stem cells inducing epithelial-mesenchymal transition in HPV-associated cervical cancer through activation of miR-129. · 5/10 · miR-129 is significantly upregulated in HPV-associated cervical cancer and shows potential as a diagnostic and prognostic biomarker. PMID42929405 · Protective effects of quercetin in experimental ulcerative colitis: Potential involvement of ERK-MMP signaling. · 4/10 · Quercetin showed protective effects in experimental UC models and these effects may be associated with modulation of the ERK-MMP signaling axis. PMID42929411 · P4HA3 promotes gastric cancer cell proliferation and invasion via the PI3K/AKT/mTOR signaling pathway and regulates glycolytic metabolic reprogramming. · 4/10 · Mechanistically, the glycolysis-enhancing effects of P4HA3 were found to require PI3K/AKT/mTOR signaling (as shown by inhibitor studies).

📊 TODAY'S BREAKDOWN

🔧 RUN NOTES